Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29008264 | 0.98 | EGLN3 (0.34) | EGLN3KDM4EPOLBMEN1HSP90AA1 | |
| Bromide SCHEMBL571256 | 0.98 | MEN1 (0.33) | EGLN3KDM4EPOLBMEN1HSP90AA1 | |
| SCHEMBL35213 | 0.89 | LMNA (0.34) | KDM4EMEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL6115678 | 0.87 | TBXAS1 (0.36) | EGLN3KDM4EMEN1HSP90AA1KMT2A | |
| SCHEMBL18211781 | 0.86 | TSHR (0.40) | MEN1KMT2A | |
| SCHEMBL22916707 | 0.86 | TSHR (0.40) | MEN1KMT2A | |
| SCHEMBL18211773 | 0.86 | TSHR (0.40) | MEN1KMT2A | |
| SCHEMBL4249049 | 0.85 | MEN1 (0.37) | MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Bromide SCHEMBL1977150 | 0.84 | TSHR (0.39) | MEN1KMT2A | |
| SCHEMBL29002029 | 0.83 | MEN1 (0.30) | MEN1HSP90AA1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9999217-B2 | Compositions for stabilizing DNA, RNA, and proteins in blood and other biological samples during shipping and storage at ambient temperatures | BIOMATRICA, INC. (US) | 2018-06-19 | — | — | US | claimed |
| EP-2598661-B1 | COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN SALIVA AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES | BIOMATRICA INC (US) | 2017-09-27 | — | — | EP | claimed |
| EP-2598660-B1 | COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES | BIOMATRICA INC (US) | 2017-03-15 | — | — | EP | claimed |
| EP-1698686-B1 | Co-Production of olefins and esters via ethenolysis of unsaturated fats in non-aqueous ionic liquids. | INST FRANCAIS DU PETROLE (FR) | 2012-11-07 | — | — | EP | claimed |
| EP-1810961-B1 | Method of co-producing olefins and diesters or diacids by homometathesis of unsaturated fatty bodies in non-aqueous ionic liquids | INST FRANCAIS DU PETROLE (FR) | 2010-12-29 | — | — | EP | claimed |
| US-7754904-B2 | Process for co-producing olefins and diesters or diacids by homomethathesis of unsaturated fats in non-aqueous ionic liquids | INSTITUT FRANCAIS DU PETROLE (FR) | 2010-07-13 | — | — | US | claimed |
| US-7678932-B2 | Process for co-producing olefins and esters by ethenolysis of unsaturated fats in non-aqueous ionic liquids | INSTITUT FRANCAIS DU PETROLE (FR) | 2010-03-16 | — | — | US | claimed |
| US-20070179302-A1 | PROCESS FOR CO-PRODUCING OLEFINS AND DIESTERS OR DIACIDS BY HOMOMETHATHESIS OF UNSATURATED FATS IN NON-AQUEOUS IONIC LIQUIDS | INSTITUT FRANCAIS DU PETROLE (FR) | 2007-08-02 | — | — | US | claimed |
| US-20060079704-A1 | Process for co-producing olefins and esters by ethenolysis of unsaturated fats in non-aqueous ionic liquids | INSTITUT FRANCAIS DU PETROLE (FR) | 2006-04-13 | — | — | US | claimed |
| US-20060070919-A1 | Process for separating oxygen-containing compounds contained in a hydrocarbon feed, employing an ionic liquid | INSTITUT FRANCAIS DU PETROLE (FR) | 2006-04-06 | — | — | US | claimed |
| US-9999217-B2 | Compositions for stabilizing DNA, RNA, and proteins in blood and other biological samples during shipping and storage at ambient temperatures | BIOMATRICA, INC. (US) | 2018-06-19 | — | — | US | disclosed |
| EP-3104383-A1 | CARRIER AND PHOTOELECTRIC CONVERSION ELEMENT | Adeka Corporation (JP) | 2016-12-14 | — | — | EP | disclosed |
| US-20160338342-A1 | COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES | EXACT SCIENCES CORPORATION | 2016-11-24 | — | — | US | disclosed |
| US-20160329161-A1 | CARRIER SYSTEM AND PHOTOELECTRIC CONVERSION DEVICE | ADEKA CORPORATION (JP) | 2016-11-10 | — | — | US | disclosed |
| US-9376709-B2 | Compositions for stabilizing DNA and RNA in blood and other biological samples during shipping and storage at ambient temperatures | BIOMATRICA, INC. (US) | 2016-06-28 | — | — | US | disclosed |
| WO-2009114830-A2 | METHODS AND COMPOSITIONS FOR EXTRACTION AND TRANSESTERIFICATION OF BIOMASS COMPONENTS | UNIVERSITY OF HAWAII (US) | 2009-09-17 | — | — | WO | disclosed |
| US-20090234146-A1 | METHODS AND COMPOSITIONS FOR EXTRACTION AND TRANSESTERIFICATION OF BIOMASS COMPONENTS | UNIVERSITY OF HAWAII (US) | 2009-09-17 | — | — | US | disclosed |
| US-20070179302-A1 | PROCESS FOR CO-PRODUCING OLEFINS AND DIESTERS OR DIACIDS BY HOMOMETHATHESIS OF UNSATURATED FATS IN NON-AQUEOUS IONIC LIQUIDS | INSTITUT FRANCAIS DU PETROLE (FR) | 2007-08-02 | — | — | US | disclosed |
| US-20060079704-A1 | Process for co-producing olefins and esters by ethenolysis of unsaturated fats in non-aqueous ionic liquids | INSTITUT FRANCAIS DU PETROLE (FR) | 2006-04-13 | — | — | US | disclosed |
| US-20060070919-A1 | Process for separating oxygen-containing compounds contained in a hydrocarbon feed, employing an ionic liquid | INSTITUT FRANCAIS DU PETROLE (FR) | 2006-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070179302-A1 | PROCESS FOR CO-PRODUCING OLEFINS AND DIESTERS OR DIACIDS BY HOMOMETHATHESIS OF UNSATURATED FATS IN NON-AQUEOUS IONIC LIQUIDS | FADS2, SCD, FADS1 | EGLN3 2903/4885KDM4E 4737/4885POLB 1299/4885 |
| US-20160338342-A1 | COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES | HNRNPD, HNRNPDL, HNRNPL | EGLN3 3475/4885KDM4E 3252/4885POLB 91/4885 |
| US-20060079704-A1 | Process for co-producing olefins and esters by ethenolysis of unsaturated fats in non-aqueous ionic liquids | ELOVL3, ELOVL1, FASN | EGLN3 1646/4885KDM4E 4537/4885POLB 1299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.